DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Olfactory transduction	R-HSA-9751605	map04740	carbamazepine	2554	drug-path
Asthma	R-HSA-444620	map05310	carbamazepine	2554	drug-path
MAPK signaling pathway	R-HSA-9652817	map04010	carbamazepine	2554	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	carbamazepine	2554	drug-path
Alzheimer's disease	R-HSA-1643685	0	carbamazepine	2554	drug-path
Focal adhesion	R-HSA-354113	map04510	carbamazepine	2554	drug-path
Parkinson's disease	R-HSA-1643685	0	carbamazepine	2554	drug-path
Cytokine-cytokine receptor interaction	R-HSA-6788467	map04060	carbamazepine	2554	drug-path
Small cell lung cancer	R-HSA-5619066	map05222	carbamazepine	2554	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	blebbistatin	6473883	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	blebbistatin	6473883	drug-path
Antigen processing and presentation	R-HSA-1236975	map04612	blebbistatin	6473883	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	blebbistatin	6473883	drug-path
Allograft rejection	R-HSA-9679028	map05330	blebbistatin	6473883	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	blebbistatin	6473883	drug-path
Olfactory transduction	R-HSA-9751605	map04740	natamycin	5284447	drug-path
Axon guidance	R-HSA-422475	map04360	natamycin	5284447	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	natamycin	5284447	drug-path
Shigellosis	0	map05131	natamycin	5284447	drug-path
Pathogenic Escherichia coli infection	R-HSA-9609646	map05130	natamycin	5284447	drug-path